Ascend Wellness (AWWH) Stock Price, News & Analysis

Company Overview

Ascend Wellness is a vertically integrated cannabis company that cultivates, processes and distributes a broad portfolio of adult‐use and medical cannabis products. The company operates under the Ascend brand, focusing on consumer packaged goods and retail operations, and offers a selection of flower, pre‐rolls, concentrates, vape cartridges, edibles and tinctures.

Since its founding in 2018 and headquartered in Boston, Ascend Wellness has expanded its footprint through the development of cultivation and manufacturing facilities, as well as the opening and acquisition of retail dispensaries. Its state‐licensed production sites use controlled environment agriculture techniques to ensure product consistency and quality.

Ascend Wellness’s dispensaries serve adult‐use and medical cannabis customers in multiple U.S. states, including Massachusetts, Illinois, Pennsylvania and New Jersey. The company’s retail network is designed to offer a standardized shopping experience, with knowledgeable staff providing guidance on product selection and dosing.

While the company continues to grow its geographic presence and product offerings, Ascend Wellness remains focused on research and development to introduce new formulations and delivery methods. Its vertically integrated model is intended to streamline supply chain efficiencies and maintain rigorous quality standards across all operations.

Key Stats

• Today's Range: $0.41 to $0.44
• 50-Day Range: $0.38 to $0.56
• 52-Week Range: $9.31 to $11.79
• Volume: 159,965 shs
• Average Volume: 12,015 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:AWWH
• CIK: N/A
• Web: www.awholdings.com
• Phone: 781 703 7800
• Fax: N/A
• Employees: 1,800
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A